Loading insider details...
Beta
Latest Form 4 (May 13, 2026): Purchase of 25,000 RNTX shares, $25.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 13, 2026 | Rein Therapeutics, Inc. (RNTX) | Purchase | 25,000 | $25.0K |
| Dec 9, 2024 | Aileron Therapeutics, Inc. (ALRN) | Purchase | 239 | $535.36 |
| Dec 4, 2024 | Aileron Therapeutics, Inc. (ALRN) | Grant/Award | 517,500 | n/a |
| Mar 6, 2024 | AILERON THERAPEUTICS INC (ALRN) | Exercise/Conversion | 2,000 | n/a |
| Dec 18, 2023 | AILERON THERAPEUTICS INC (ALRN) | Purchase | 225 | $758.25 |
| Nov 21, 2023 | AILERON THERAPEUTICS INC (ALRN) | Purchase | 5,076 | $10.0K |